Original language | English |
---|---|
Pages (from-to) | e310-e313 |
Journal | The Lancet Rheumatology |
Volume | 4 |
Issue number | 5 |
DOIs |
|
Publication status | Published - 1 May 2022 |
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
Laura Boekel, Femke Hooijberg, Yaëlle R. Besten, Erik H. Vogelzang, Maurice Steenhuis, Maureen Leeuw, Sadaf Atiqi, Ronald van Vollenhoven, Willem F. Lems, Wouter H. Bos, Carla A. Wijbrandts, Martijn Gerritsen, Charlotte Krieckaert, Alexandre E. Voskuyl, Irene E. van der Horst-Bruinsma, Sander W. Tas, Maarten Boers, Theo Rispens, Michael T. Nurmohamed, Gertjan Wolbink
- Rheumatology (VUmc)
- AII - Inflammatory diseases (VUmc)
- APH - Societal Participation & Health (VUmc)
- Medical Microbiology and Infection Prevention (VUmc)
- AMS - Musculoskeletal Health (VUmc)
- AMS - Tissue Function & Regeneration
- AII - Infectious diseases (VUmc)
- Epidemiology and Data Science (VUmc)
- APH - Methodology (VUmc)
- ACS - Atherosclerosis & ischemic syndromes (VUmc)
- Clinical Immunology and Rheumatology (AMC)
- AII - Inflammatory diseases (AMC)
- AMS - Musculoskeletal Health
- Experimental Immunology (AMC)
- Landsteiner Laboratory (AMC)
Research output: Contribution to journal › Comment/Letter to the editor › Academic
12
Citations
(Scopus)